Neumora Therapeutics Inc. Common Stock (NMRA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Neumora Therapeutics Inc....

    NASDAQ: NMRA · Real-Time Price · USD
    1.70
    -0.13 (-7.10%)
    At close: Sep 25, 2025, 3:59 PM
    1.69
    -0.61%
    After-hours: Sep 25, 2025, 07:28 PM EDT

    Neumora Therapeutics Common Stock Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a 668K 2.7M 1.55M
    Gross Profit
    		 n/a -668K -2.7M -1.55M
    Operating Income
    		 -263.46M -188.19M -135.87M -237.32M
    Interest Income
    		 19.93M 16.61M 4.56M n/a
    Pretax Income
    		 -243.61M -235.66M -130.9M -237.31M
    Net Income
    		 -243.79M -235.93M -130.9M -237.31M
    Selling & General & Admin
    		 62.54M 44.81M 31.12M 24.55M
    Research & Development
    		 200.93M 142.72M 104.75M 212.78M
    Other Expenses
    		 n/a n/a 405K 11K
    Operating Expenses
    		 263.46M 187.53M 135.87M 237.32M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a -668K n/a n/a
    Cost & Expenses
    		 n/a 188.19M 135.87M 237.32M
    Income Tax Expense
    		 178K 268K n/a 301.44K
    Shares Outstanding (Basic)
    		 159.38M 158.83M 151.95M 151.95M
    Shares Outstanding (Diluted)
    		 159.38M 158.83M 151.95M 151.95M
    EPS (Basic)
    		 -1.53 -1.49 -0.86 -1.56
    EPS (Diluted)
    		 -1.53 -1.49 -0.86 -1.56
    EBITDA
    		 -242.98M -187.53M -135.28M -236.78M
    EBIT
    		 -243.61M -188.19M n/a -237.32M
    Depreciation & Amortization
    		 631K 668K 2.7M 1.55M

    Add to Watchlist